New-onset drug-resistant epilepsy in type 1 diabetes mellitus patient following COVID-19 vaccination: suspicious for autoimmune pathogenesis
This case exemplifies the diagnostic challenges inherent in autoimmune-associated epilepsy and underscores the necessity for prompt intervention. Glutamic acid decarboxylase (GAD65) antibody-associated autoimmune epilepsy should be suspected in adult-onset temporal lobe epilepsy with co-morbid type 1 DM with early initiation of immune therapy for better clinical outcomes.
Authors
- Michael Baghdadi (ORCID: https://orcid.org/0000-0003-0553-9518)
- Nirmeen A. Kishk
- Ibrahim Elmenshawi (ORCID: https://orcid.org/0000-0002-1084-1036)
- Amani M. Nawito (ORCID: https://orcid.org/0000-0001-8702-4117)
- Hadeer Elsaeed AboElfarh (ORCID: https://orcid.org/0000-0003-2632-3775)
- Sally Shaaban (ORCID: https://orcid.org/0000-0001-5881-9607)
- Ahmed Hamdy (ORCID: https://orcid.org/0000-0002-3646-9594)
- Mohamed Eladrousi
- Marwa El Sayed Elktob
- Mohamed Elfieshy
Institutions
- Cairo University (EG)
- Mansoura University (EG)
- Ministry of Communication and Information Technology (ET)
- Ministry Of Health (FJ)
- Ministry of Health and Population (EG)
Publication Details
- Journal
- BMC Neurology
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1186/s12883-025-04126-3
- Citations
- 1
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.39